A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China

Clinical trial NCT04825873 · COMPLETED

Trial details

NCT number: NCT04825873
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer Squamous Cell Carcinoma of Head and Neck

Start date: 2021-05-28
Primary completion: 2023-02-13
Enrollment: 3102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.